Myriad Uranium Enters into Option to Acquire 100% of the Red Basin Uranium Project in New Mexico, USA
Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it has ...
Pharmabiz4h
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...
decrypt10d
MYRIAD Launches on Abstract as Mainnet Goes Live
The decentralized prediction market is one of the main apps featured on Abstract’s portal for the Abstract Global Wallet.
Myriad Uranium Announces Resignation of Director
Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") announces that Ian Archbold has assumed a ...
Myriad Genetics获得癌症微小残留病（MRD）检测专利
盐湖城 - 年收入达8.24亿美元的基因检测和精准医疗公司Myriad Genetics, Inc. (NASDAQ: ...
Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay
In 2024, Myriad Genetics was awarded three patents related to foundational platform MRD technology and cell-free DNA preparation methods that each enable highly sensitive and specific tumor-informed, ...